Table 2.
24-h CGM data of each HbA1c group
| HbA1c | Group A HbA1c ≤7.2 % |
Group B 7.2 % <HbA1c ≤8.2 % |
Group C | Group D HbA1c >9.2 % |
P value |
|---|---|---|---|---|---|
| 8.2 % <HbA1c ≤9.2 % | |||||
| Mean glucose levels (mg/dL)a | 133.0 (113.5‒154.8) |
157.5 (131.5‒187.5) |
182.0 (152.0‒206.0) |
186.0 (143.0‒214.8) |
<0.001 |
| SDa | 53.0 (40.0‒65.0) |
53.5 (44.8‒69.8) |
64.0 (55.0‒76.0) |
58.0 (48.0‒80.0) |
0.165 |
| MAGE (mg/dL)a |
99.3
(62.4–149.0) |
99.7
(78.5–130.3) |
103.3
(81.8–127.9) |
89.8
(66.7–119.6) |
0.783 |
| %CV a |
40.7
(32.8–51.2) |
34.0
(30.8–45.1) |
37.6
(30.1–41.0) |
36.8
(27.1–45.6) |
0.405 |
| J-index a |
38.7
(24.8–44.1) |
51.0
(31.5–61.5) |
64.7
(44.1–82.6) |
65.2
(40.5–82.8) |
<0.001 |
| M value a |
10.9
(6.7–20.2) |
15.1
(7.6–18.3) |
17.5
(10.3–29.9) |
19.4
(9.6–27.4) |
0.126 |
| MODD (mg/dL)a |
43.9
(31.3–54.4) |
53.5
(41.8–64.1) |
53.5
(39.7–89.6) |
57.7
(41.0–81.4) |
0.163 |
| Time in hypoglycemia (min)a | 170.0 (57.5‒341.3) |
77.5 (0‒210.0) |
45.0 (0‒105.0) |
20.0 (0‒105.0) |
0.014 |
| Time in nocturnal hypoglycemia (min)a | 120.0 (5.0‒268.8) |
25.0 (0‒120.0) |
0 (0‒60.0) |
0 (0‒88.8) |
0.019 |
| LBGI a |
5.7
(2.6–9.0) |
3.6
(0.9–6.8) |
3.9
(1.2–10.8) |
2.2
(0.6–5.6) |
0.162 |
| Time in hyperglycemia (min)a | 335.0 (147.5‒446.3) |
457.5 (193.8‒722.5) |
715.0 (425.0‒945.0) |
675.0 (351.3‒953.8) |
0.001 |
| HBGI a |
8.1
(5.4–9.3) |
10.9
(6.0–13.8) |
13.2
(8.4–19.4) |
13.7
(6.6–20.4) |
0.003 |
Data presented as median (25–75 percentiles)
Italic values indicate significance of P value (P < 0.05)
aKruskal–Wallis test